350 related articles for article (PubMed ID: 23977191)
1. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.
Kim IM; Tilley DG; Chen J; Salazar NC; Whalen EJ; Violin JD; Rockman HA
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14555-60. PubMed ID: 18787115
[TBL] [Abstract][Full Text] [Related]
3. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.
Wisler JW; DeWire SM; Whalen EJ; Violin JD; Drake MT; Ahn S; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16657-62. PubMed ID: 17925438
[TBL] [Abstract][Full Text] [Related]
4. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
[TBL] [Abstract][Full Text] [Related]
5.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
6. Action and disposition of the β3-agonist nebivolol in the presence of inflammation; an alternative to conventional β1-blockers.
Sanaee F; Jamali F
Curr Pharm Des; 2014; 20(9):1311-7. PubMed ID: 23978104
[TBL] [Abstract][Full Text] [Related]
7. Gα
Wang J; Hanada K; Staus DP; Makara MA; Dahal GR; Chen Q; Ahles A; Engelhardt S; Rockman HA
Nat Commun; 2017 Nov; 8(1):1706. PubMed ID: 29167435
[TBL] [Abstract][Full Text] [Related]
8. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
9. Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
Daniele S; Trincavelli ML; Fumagalli M; Zappelli E; Lecca D; Bonfanti E; Campiglia P; Abbracchio MP; Martini C
Cell Signal; 2014 Jun; 26(6):1310-25. PubMed ID: 24613411
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.
Violin JD; Ren XR; Lefkowitz RJ
J Biol Chem; 2006 Jul; 281(29):20577-88. PubMed ID: 16687412
[TBL] [Abstract][Full Text] [Related]
11. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.
Peitzman ER; Zaidman NA; Maniak PJ; O'Grady SM
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L50-8. PubMed ID: 26566905
[TBL] [Abstract][Full Text] [Related]
13. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
14. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebivolol on human platelet aggregation.
Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.
Zhang Z; Ding L; Jin Z; Gao G; Li H; Zhang L; Zhang L; Lu X; Hu L; Lu B; Yu X; Hu T
PLoS One; 2014; 9(5):e98179. PubMed ID: 24849208
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic effects of nebivolol and carvedilol: Involvement of β2 receptors and COX-2/PGI2 pathways.
Kozlovski VI; Lomnicka M; Bartus M; Sternak M; Chlopicki S
Pharmacol Rep; 2015 Oct; 67(5):1041-7. PubMed ID: 26398401
[TBL] [Abstract][Full Text] [Related]
18. beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling.
Tilley DG; Kim IM; Patel PA; Violin JD; Rockman HA
J Biol Chem; 2009 Jul; 284(30):20375-86. PubMed ID: 19509284
[TBL] [Abstract][Full Text] [Related]
19. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
Jensen DD; Godfrey CB; Niklas C; Canals M; Kocan M; Poole DP; Murphy JE; Alemi F; Cottrell GS; Korbmacher C; Lambert NA; Bunnett NW; Corvera CU
J Biol Chem; 2013 Aug; 288(32):22942-60. PubMed ID: 23818521
[TBL] [Abstract][Full Text] [Related]
20. β-Arrestin-biased signaling mediates memory reconsolidation.
Liu X; Ma L; Li HH; Huang B; Li YX; Tao YZ; Ma L
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4483-8. PubMed ID: 25831532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
